Clinical Trial Update: Primary Hyperaldosteronism and Ischemia-reperfusion Injury [NA]

View source ↗

Summary

A completed clinical trial at Radboud University Medical Center investigated primary hyperaldosteronism and ischemia-reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperaldosteronism

Snippet

Sponsor: Radboud University Medical Center | Conditions: Primary Hyperaldosteronism | NA | Status: COMPLETED